Skip to main content

Membranous Nephropathy clinical trials at University of California Health

2 research studies open to eligible people

Showing trials for
  • Belimumab With Rituximab for Primary Membranous Nephropathy

    open to eligible people ages 18-75

    The primary objective of this study is to evaluate the effectiveness of belimumab and intravenous rituximab co-administration at inducing a complete or partial remission (CR or PR) compared to rituximab alone in participants with primary membranous…

    at UCLA UCSF

  • Nephrotic Syndrome Study Network

    open to eligible people ages up to 80 years

    Minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), and Membranous nephropathy (MN), generate an enormous individual and societal financial burden, accounting for approximately 12% of prevalent end stage renal disease (ESRD)…

    at UCLA UCSF

Our lead scientists for Membranous Nephropathy research studies include .

Last updated: